Position in ABBV
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$44,288
+$11,013 QoQ
Shares Held
176
+15.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#4,079
of 4,153 holders
Holding Since
Mar 2023
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Strengthening Families & Communities, LLC holds $15,119,704 across 12 Drug Manufacturers - General names. ABBV ranks #6 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
21,481 | $5,455,529 | |
| 2 | MRK |
Merck & Co., Inc.
|
41,350 | $5,313,475 | |
| 3 | LLY |
ELI LILLY & Co
|
3,421 | $4,103,250 | |
| 4 | AZN |
Astrazeneca PLC
|
506 | $95,947 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
427 | $53,947 | |
| 6 | ABBV |
AbbVie Inc.
This page
|
176 | $44,288 | |
| 7 | AMGN |
Amgen Inc
|
75 | $27,159 | |
| 8 | NVS |
Novartis AG
|
100 | $15,672 |
All Filings in ABBV
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,288 | 176 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $33,275 | 153 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $50,496 | 221 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $11,577 | 50 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $9,281 | 50 | Shares | Sole | 2025-07-24 | |
| 2025-03-31 | $5,238 | 25 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $3,909 | 22 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $4,344 | 22 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $3,773 | 22 | Shares | Sole | 2024-07-22 | |
| 2023-03-31 | $23,905 | 150 | Shares | Sole | 2023-05-04 | |
| No filing history on record for this holder in this stock. | ||||||